Cargando…
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Receptor-PI3K-mTORC1 signaling and fatty acid synthase (FASN)-regulated lipid biosynthesis harbor numerous drug targets and are molecularly connected. We hypothesize that unraveling the mechanisms of pathway cross-talk will be useful for designing novel co-targeting strategies for ovarian cancer (OC...
Autores principales: | Wagner, Renate, Stübiger, Gerald, Veigel, Daniel, Wuczkowski, Michael, Lanzerstorfer, Peter, Weghuber, Julian, Karteris, Emmanouil, Nowikovsky, Karin, Wilfinger-Lutz, Nastasia, Singer, Christian F., Colomer, Ramón, Benhamú, Bellinda, López-Rodríguez, María Luz, Valent, Peter, Grunt, Thomas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355289/ https://www.ncbi.nlm.nih.gov/pubmed/28086243 http://dx.doi.org/10.18632/oncotarget.14591 |
Ejemplares similares
-
Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry
por: Rogers-Broadway, Karly-Rai, et al.
Publicado: (2019) -
Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer
por: Grunt, Thomas W., et al.
Publicado: (2020) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)